Fibrinolytic Pseudomonas spp. QMS71 from mangrove wetlands and its application
By isolating and screening the wetland pseudobacterium QMS71 strain from mangrove wetlands, the problem of scarce microbial resources in existing technologies has been solved, and stable fibrin degradation under mesophilic and high-salt environments has been achieved, thus expanding the microbial sources for fibrin degradation research.
CN122303083APending Publication Date: 2026-06-30JIANGSU OCEAN UNIV
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- JIANGSU OCEAN UNIV
- Filing Date
- 2026-03-23
- Publication Date
- 2026-06-30
Smart Images
Figure CN122303083A_ABST
Abstract
This invention discloses a fibrinolytic enzyme-producing Pseudomonas hygroscopicus originating from mangrove wetlands (… Fictibacillus rigui The strain QMS71 is deposited at the China General Microbiological Culture Collection Center (CGMCC) under accession number CGMCC No. 37018. Under suitable culture conditions, strain QMS71 can produce extracellular enzymes with fibrin-degrading activity. Its fermentation products exhibit significant fibrin degradation activity in vitro and demonstrate thrombolytic and anticoagulant activities in relevant in vitro functional evaluation models. This invention provides a well-identified fibrinolytic enzyme-producing microbial resource and its applications, which can be used for in vitro functional evaluation, model studies, and functional enzymology research related to fibrin degradation.
Need to check novelty before this filing date? Find Prior Art